awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27004032-22B17483-D0B5-4386-A430-CFE044AEC9AD
Q27004032-22B17483-D0B5-4386-A430-CFE044AEC9AD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27004032-22B17483-D0B5-4386-A430-CFE044AEC9AD
Clinical advances in the management of chronic myelogenous leukemia: focus on bosutinib and patient considerations
P2860
Q27004032-22B17483-D0B5-4386-A430-CFE044AEC9AD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27004032-22B17483-D0B5-4386-A430-CFE044AEC9AD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
14ddd0919fdcd610cf0a3bd37576b453fba137e8
P2860
Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results